According to ORIC Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.22 Billion a decrease over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | -A$0.23 Billion | 2.85% |
2024 | -A$0.22 Billion | 28.99% |
2023 | -A$0.17 Billion | 27.68% |
2022 | -A$0.14 Billion | 10.01% |
2021 | -A$0.13 Billion | 59.84% |
2020 | -A$75.51 Million | 72.72% |
2019 | -A$43.72 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -A$0.23 Billion | 0.00% | ๐บ๐ธ USA |